Semaglutide has emerged as a novel treatment for type 2 diabetes. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and curbing glucagon https://matteorzgq764509.vidublog.com/34646828/grasping-semaglutide-a-comprehensive-guide